BioCorRx (BICX) Receivables - Net (2010 - 2026)

BioCorRx has disclosed Receivables - Net across 17 years of filings, most recently posting $330348.0 for Q1 2026.

• Receivables - Net for Q1 2026 came in at $330348.0, up 195.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $330348.0 (up 195.04% YoY), and the FY2025 annual result was $253459.0, changed N/A from the prior year.
• Receivables - Net came in at $330348.0 for Q1 2026 at BioCorRx, up from $253459.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $330348.0 in Q1 2026 to a low of $10393.0 in Q1 2022.
• The 5-year median for Receivables - Net is $109736.0 (2024), against an average of $124191.5.
• Across the five-year window, Receivables - Net surged 8576.8% in 2022 and slumped 89.22% in 2023, its largest moves.
• BioCorRx's Receivables - Net stood at $130152.0 in 2022, then sank by 41.4% to $76266.0 in 2023, then surged by 311.94% to $314170.0 in 2024, then retreated by 19.32% to $253459.0 in 2025, then surged by 30.34% to $330348.0 in 2026.
• The last three Receivables - Net figures came in at $330348.0 (Q1 2026), $253459.0 (Q4 2025), and $194442.0 (Q3 2025), per Business Quant data.